Bright Rex 4
4 · Foamix Pharmaceuticals Ltd. · Filed May 20, 2019
Insider Transaction Report
Form 4
Bright Rex
Director
Transactions
- Award
Options
2019-05-16+49,412→ 49,412 totalExercise: $2.66Exp: 2029-05-16→ Ordinary Shares (49,412 underlying)
Footnotes (2)
- [F1]Each option represents a contingent right to purchase one ordinary share of the issuer.
- [F2]The ordinary shares underlying these options vest over a 12 month period, in equal, quarterly installments, ending May 16, 2020.